Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic Umbilical Cord Mesenchymal Stem Cells

umbilical cord-derived mesenchymal stem cells · Ever Supreme Bio Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Allogeneic Umbilical Cord Mesenchymal Stem Cells, covering 2016-05-05 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis [Phase 1, Phase 2]

See pricing